Therefore, it is recognized that the IGF/IGF-1R system is involved in colorectal carcinogenesis and therefore may be a potential molecular target that could help in the prevention and treatment of CRC [16,38,39,40]. The gene discussed is IGF1; the disease is colorectal carcinoma.